Clinical Trial Update: Safety and Efficacy of a Combination Product for the Prevention of Veisalgia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of a combination product intended to prevent veisalgia (hangovers); results completed and posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hangover

Drugs mentioned

• Combination product for hangover prevention (unspecified)

Snippet

Sponsor: Sen-Jam Pharmaceutical | Conditions: Veisalgia | Phase 2 | Status: COMPLETED | Results posted: 2018-07-19